Solving the Capacity Crisis for Viral Vector Manufacturing
Solving the Capacity Crisis for Viral Vector Manufacturing
Viral vectors for gene therapy have shown tremendous clinical promise which has spurred a huge increase in demand for manufacturing space, resulting in a capacity crisis. This is currently delaying the commercialization of these gene therapies for which time to market is critical.
Integrated solutions for viral vectors designed within modular cleanroom facilities streamline manufacturing and reduce time to market. Pall Biotech and G-CON manufacturing have partnered to design and deploy an integrated manufacturing solution to address the current capacity constraints for viral vector manufacturing.
Participants will learn:
- The manufacturing challenges facing the viral vector industry
- The advantages of an integrated manufacturing solution
- How to develop and deploy a new manufacturing facility in 10 months within a modular cleanroom
Moderator
Clive Glover
Director, Cell & Gene Therapy
Pall Biotech
Biography
Presenters
Jeremy Rautenbach
Global Product Manager, Integrated Solutions
Pall Biotech
Joseph Rininger
Director, Cell & Gene Therapy
Latham BioPharm Group
Peter Makowensky
Director, Sales Engineering
G-CON Manufacturing
Maximize Speed to Market Flexibility of Single-Use for Gene Therapy Manufacturing
Listen to Podcast Today
Biotech | Pall Corporation 웨비나 시리즈
Integrity Assurance for Single-Use Systems An End-User’s Perspective
What should you consider when building an integrity control strategy for your single-use systems (SUS)? How do you overcome application challenges?
Join leading industry experts Charlotte Masy of GSK and Patrick Evrard from Pall Corporation to gain insights and answers in this webinar from BioPharma Asia on integrity Assurance for Single-Use Systems, an End-User’s Perspective. They will present several case studies to show how integrity concerns can be practically addressed for cGMP manufacturing applications and the results observed a few years on.
Attendees will learn about:
- The latest regulatory requirements for integrity assurance of SUS
- The different technologies available to control integrity of SUS
- Key parameters that affect integrity measurements
Register now for this webinar from industry experts on October 6.